Hype, page-34

I am a big supporter of UNILIFE and I do think AS has done an amazing job, to get it where it is in terms of deals and products plus the potential, but to have the SP at this level with the current outlook and product line due to a lack of guidance and data is extremely frustrating and not right.
Also the management team is too smug for my liking.
Yes it was all hush hush due to MS Review and Amgen deal but that's done and ..... NO UPDATES.
Frustrating to say the least.
The SP should easily be over $1 IMO given where the company is and the potential to be huge.
Instead silence and 20 cents.
Why does a company not care about the SP undervalued??
At least we now have a new CFO need a few others changed as well.
Investor relations team good place to look.